UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | May 20, 2015 |
CannaPharmaRx, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| Delaware | 000-27055 | 27-4635140 |
|
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| One Collins Drive, Suite 100, Carneys Point, New Jersey | 08069 | |
|
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
| Registrant’s telephone number, including area code: | 856-376-0500 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On May 20, 2015, the Board of Directors of CannaPharmaRx, Inc., a Delaware corporation (the "Company"), resolved that its 2015 Annual Meeting of the stockholders of the Company will be held on Friday, August 14, 2015 at 9am EDT, at its corporate headquarters located at One Collins Drive, Suite 100, Carneys Point, NJ 08069-3640. The Board also approved June 26, 2015 as the record date for the 2015 Annual Meeting. Only stockholders of record as of the close of business on June 26, 2015 may attend and vote at the 2015 Annual Meeting or any adjournment thereof.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CannaPharmaRx, Inc. | ||||
| May 27, 2015 | By: |
/s/ Gerald E. Crocker
|
||
|
|
||||
| Name: Gerald E. Crocker | ||||
| Title: Chief Executive Officer and Director | ||||